Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial. (Q52618143)
Jump to navigation
Jump to search
scientific article published on 27 March 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial. |
scientific article published on 27 March 2018 |
Statements
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial (English)
Eric O Ochomo
Ghaith Aljayyoussi
Titus K Kwambai
Bernard O Abong'o
Tao Chen
Hannah C Slater
David Waterhouse
Nabie M Bayoh
John E Gimnig
Aaron M Samuels
Meghna R Desai
Simon K Kariuki